Thomas Steyer’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Thomas Steyer’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,844,757	Closed	-$33.2M	–	145
2020 Q2	$33.2M	Buy	+1,844,757	New	+$25.7M	0.27%	69
2017 Q3	–	Sell	-855,000	Closed	-$48M	–	96
2017 Q2	$48M	Buy	855,000 +470,000	+122%	+$18.8M	0.5%	38
2017 Q1	$15.1M	Buy	385,000 +285,000	+285%	+$9.08M	0.17%	58
2016 Q4	$2.24M	Buy	+100,000	New	+$1.95M	0.03%	70

Thomas Steyer's PTLA Position: Q3 2020 in Review

Thomas Steyer sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 1,844,757 shares — an estimated $33.2M sold.

Thomas Steyer first reported a position in PTLA in Q4 2016 and held it in 4 quarters. The position peaked at $48M in Q2 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Thomas Steyer reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Thomas Steyer sold 1,844,757 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $33.2M.
Thomas Steyer first reported a position in Portola Pharmaceuticals, Inc. in Q4 2016 and held it in 4 quarters.
Thomas Steyer's Portola Pharmaceuticals, Inc. position peaked at $48M in Q2 2017.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Farallon Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.